4//SEC Filing
Clark William D 4
Accession 0000950170-25-055900
CIK 0001341235other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:41 PM ET
Size
5.4 KB
Accession
0000950170-25-055900
Insider Transaction Report
Form 4
Clark William D
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-17+76,760→ 76,760 totalExercise: $2.19Exp: 2035-04-16→ Common Stock (76,760 underlying)
Footnotes (1)
- [F1]The stock option is exercisable in equal annual installments over three years of continuous service to the Issuer after April 17, 2025.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001355415
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 4:41 PM ET
- Size
- 5.4 KB